News

Microblading, a cosmetic technique that employs fine needles to deposit pigment to mimic the appearance of hairs, may be among triggers for sarcoidosis, according to a study. “When esthetic procedures become increasingly popular, patients with chronic lesions at the injection site of the foreign material, especially macular, papular, or…

People with sarcoidosis in the U.S. are more likely than those in the general population to have certain co-occurring autoimmune disorders, including lupus and multiple sclerosis (MS). That’s according to “Autoimmune comorbidities associated with sarcoidosis: a case-control study in the All of Us research program,” which…

A 79-year-old  woman was diagnosed with spinal sarcoidosis based on the analysis of skin lesions from her scalp, according to a case study from Japan. Although a spinal MRI revealed the presence of spinal cord lesions, their cause was unknown. The presence of skin granulomas, observed in a scalp…

A 37-year-old woman in Japan developed a granuloma — the clumps of cells that characterize sarcoidosis — in her thyroid gland that spontaneously regressed without steroid treatment, a case study reports. The woman also showed lesions in the skin and salivary gland, suggesting “thyroid sarcoidosis should be considered in…

The Foundation for Sarcoidosis Research (FSR) has launched the Coalition for Clinical Trial Equity, aimed at increasing the representation of Black and African American sarcoidosis patients in trials testing potential treatments. Despite Black Americans being 2.5 times more likely to have sarcoidosis than white Americans, these patients…

A sarcoidosis patient and ardent supporter of the Foundation for Sarcoidosis Research (FSR) was dubbed a “warrior” by the nonprofit for competing in the Ironman 70.3 Chattanooga triathlon, in Tennessee, to raise awareness of the rare condition as well as funds to fight it. The competition, held…

The lungs are affected in nearly everyone diagnosed with sarcoidosis in the Netherlands, but most patients in the country don’t have disease severe enough to warrant systemic immune-suppressing treatments at the time of diagnosis. That’s according to the findings of a new study, “Organ involvement in…

The Phase 2 clinical trial RESOLVE-Lung, which is testing namilumab as a treatment for people with chronic pulmonary sarcoidosis, is now fully enrolled. According to Kinevant Sciences, the therapy’s developer, 107 patients with hard-to-treat pulmonary sarcoidosis — disease that’s “not well-controlled despite currently available treatment” — have been…

Treatment with Remicade (infliximab) is generally effective for controlling sarcoidosis when it affects the nervous system or liver, but patients whose disease affects the skin or skeletal system aren’t as likely to respond to it, a study reports. “[Remicade] shows promise for treating patients with sarcoidosis, particularly with…

Walgreens and the Foundation for Sarcoidosis Research (FSR) have renewed their partnership to raise awareness about sarcoidosis and the importance of spring respiratory vaccines, as part of this April’s Sarcoidosis Awareness Month. Until the end of the month, all Alabama-based Walgreens stores will provide informational resources to…